An effective complaint handling system is an extremely important part of any quality system. Manufacturers should understand that any complaint received on a product shall be evaluated and, if necessary, thoroughly investigated and analysed, and corrective action shall be taken. The results of this evaluation should lead to a conclusion regarding whether the complaint was valid, what the root cause of the complaint was, and what action is necessary to prevent further occurrences. Complaints cannot be ignored. They are an excellent indicator of problems with the use, design, and/or manufacture of a product. A single complaint that is thoroughly investigated may lead a company to take remedial or corrective action. It may also take an ongoing analysis of numerous complaints before a trend is spotted that causes a company to initiate changes in their product, labelling, packaging or distribution. The regulatory expectations for both pharmaceuticals and medical devices will be emphasized as well as overview of best practices for timely and effective investigations. Trending is the only way a company can stay on top of emerging quality issues and address those that are most pressing.
Medical Device Reporting (MDR) is the mechanism for FDA to receive significant medical device adverse events from manufacturers, importers and user facilities, so they can be detected and corrected quickly. User Facilities (e.g., hospitals, nursing homes) are required to report suspected medical device related deaths to both the FDA and the manufacturers. User facilities report medical device related serious injuries only to the manufacturer. If the medical device manufacturer is unknown, the serious injury is reported by the facility to FDA. Health professionals within a user-facility should familiarize themselves with their institution procedures for reporting adverse events to the FDA.
The MDR process impacts device user facilities, manufacturers, importers, and distributors. If you are a device user facility, you must report deaths and serious injuries that a device has or may have caused or contributed to, establish and maintain adverse event files, and submit summary annual reports. If you are a manufacturer or importer, you must report deaths and serious injuries that your device has or may have caused or contributed to, you must report certain device malfunctions, and you must establish and maintain adverse event files. If you are a manufacturer, you must also submit specified follow-up.
Recall means the correction or removal of a device for human use where FDA finds that there is a reasonable probability that the device would cause serious, adverse health consequences or death. It is an action taken to address a problem with a medical device that violates FDA law. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.
A medical device recall does not always mean that you must stop using the product or return it to the company. A recall sometimes means that the medical device needs to be checked, adjusted, or fixed. If an implanted device (for example, a pacemaker or an artificial hip) is recalled, it does not always have to be removed. When an implanted device has the potential to fail unexpectedly, companies often tell doctors to contact their patients to discuss the risk of removing the device compared to the risk of leaving it in place. FDA classifies medical device recalls into three categories, representing the potential risk to public health: Class I, II, and III.
Why you should attend:
1. Understand that although FDA does not specify a standard complaint handling system, the requirements do specify certain actions that shall be included in any system
2. Grasp and comprehend the definitions and elements of the regulatory requirements for Complaint Handling, Medical Device Reporting and handling of Recalls
3. All personnel who deal with customers, or who may receive a complaint call, must be trained in the proper routing/handling of complaints
4. Provide information about FDA's Medical Device Reporting (MDR) regulation and the Voluntary Reporting program called MedWatch
5. Introduce you Medical Device Reporting and to help you better understand the process and benefits of Voluntary Reporting and responsibilities
6. Latest Amendments to the MDR Regulation to Implement FDAMA Changes
7. To Recall or Not to Recall: Issues to consider regarding whether a Field Action is required
8. Determine when a recall is required and how to manage a recall, who must report, when to report, what to report, where to report, recordkeeping requirements, FDA regulatory authority, references and guidance
9. Seminar attendees are encouraged to bring examples of their work from the functional area on the various topics as applicable for group discussion
10. Review and discuss pain points, challenges and solutions
Who Will Benefit:
1. Regulatory Affairs Management
2. Regulatory Affairs Specialist
4. Compliance Officer
5. Compliance Specialist
6. Clinical Affairs
7. Quality Assurance Management
8. Marketing & Sales
9. Distributors/Authorized Representatives
10. Legal Counsel
11. Engineering/Technical Services
Areas Covered in the seminar:
1. Reporting complaints
3. Complaint evaluation and investigation
4. Data collection and trending
5. CAPA process for investigating complaints
6. Accelerate complaints recording, investigation, reporting, escalation/triggers and closure cycle as cases are automatically routed from one stage to the next
7. Gain enterprise-wide visibility into the complaints data and track the process with performance metrics, dashboards or other indicators
8. Improve communication and teamwork on complaints across departments and functional areas
9. Drive continuous improvement by tying corrective actions with complaints for a closed loop quality process
10. Improve management of the complaint lifecycle with real-time trending and escalation of customer complaints
11. Understand the History of MDR Regulation
12. What types of Reports does the FDA receive and who must submit Mandatory Reports to the FDA?
13. Who can submit Voluntary Reports to the FDA?
14. How Does the FDA Use Medical Device Reports?
15. What are the exemptions, variances, or alternative forms of adverse event reporting requirements?
16. Basics of a Recall: Initiation, Classification and Public Warning
17. Medical Device Recall Reporting
18. Recall Responsibilities & Requirements
19. FDA's Role
20. Introduction to Medical Device Recalls: Industry Responsibilities
21. Recall Communication and Strategy
22. Monitoring and Auditing Recall Effectiveness
23. Recall Termination
24. Guidance for Industry, Trends and FDA Inspection & Enforcement Statistics and Trends
Lecture 1: Complaint Handling:
Lecture 2: Medical Device Reporting
Lecture 3: Exercise and Recap of Day 1
Lecture 4: Medical Device Reporting
Lecture 5: Recalls
Lecture 6: Exercise and Recap of Day 2
David R. Dills, Regulatory & Compliance Consultant with more than 24 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices, pharmaceutical operations, and manages activities within the global regulatory and compliance space. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses global regulatory requirements. Background encompasses broad capabilities in quality systems, validation, regulatory affairs, compliance, auditing, interfacing with the regulatory agencies, addressing enforcement actions and mitigating compliance exposure for companies via remediation, compliance engineering support, post-marketing surveillance and vigilance reporting; clinical affairs, establish and/or remediate Quality Management and documentation systems for GxP compliance; preparation for ISO 13485 registration and CE Mark; and multi-country product registrations and licensing; and working with Notified Bodies, and AR's. David manages regulatory problems (e.g. AE's, MDRs, Agency enforcement, complaints/investigations, field alerts/recalls) related to development, manufacturing, and commercialization, and recommends action to senior leadership to ensure effective resolution for manufacturers to achieve sustainable and proven compliant systems. This is based on analyzing the benefits/risks for informed decision-making and interprets the regulatory precedents and new legislation. He strives to optimize business performance through proactive strategies to mitigate compliance exposure by providing strategic and tactical solutions that facilitate the achievement of regulatory and quality milestones. David has been previously affiliated with well-known device manufacturers and service providers, including a global CRO and has served in various quality, regulatory and compliance management and advisory capacities with increasing responsibilities. David is an industry speaker and author of technical and compliance related topics published in industry journals. Please refer to his profile provided herein for additional information about his background and areas of interest and focus.
Date: 20th & 21st, March 2014
Time: 9 AM to 6 PM
Venue: Mandarin Orchard Singapore
Address: 333 Orchard Road, Singapore 238867
Price: $1595.00 (For One Delegate)
Register now and save $200. (Early Bird)
Until February 28, Early Bird Price: $1,595.00
From March 01 to May 18, Regular Price: $1,795.00
Toll free: 1800 447 9407
Fax: 302 288 6884
Live Chat Support Also - http://www.globalcompliancepanel.com/chat/client.php
NetZealous LLC, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA
For More Info Click Here: http://bit.ly/MckjqJ